Clinical Trial - Trial jRCT2031230360
Access comprehensive clinical trial information for jRCT2031230360 through Pure Global AI's free database. This phase not specified trial is sponsored by Amgen Inc. and is currently Not yet recruiting. The study focuses on Melanoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031230360
Not yet recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031230360
Untitled Trial
A Randomized, Double blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO(R) (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting
Study Focus
Interventional
Sponsor & Location
Amgen Inc.
North America;South America;Europe;Africa;Asia
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant melanoma of skin
Melanoma in situ, unspecified
Melanoma in situ
Melanoma and other malignant neoplasms of skin
Malignant neoplasm: Malignant melanoma of skin, unspecified
Data Source
Japan Registry Clinical Trial
jRCT2031230360
Non-Device Trial